Literature DB >> 19782917

Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence?

Georgios S Papaetis1, Evgenia Anastasakou, Dora Orphanidou.   

Abstract

Chlamydophila pneumoniae has been recognized as a common cause of respiratory tract infections affecting all age groups. The organism has been implicated as an infectious trigger for acute exacerbations of COPD. Moreover, the intracellular existence of this pathogen and the ability to cause chronic respiratory infections have led to a number of studies that investigated its possible association with disease development. The present paper examines and discusses the possible association of acute C. pneumoniae infection in episodes of acute exacerbation of COPD. It also reviews the existing evidence of chronic C. pneumoniae infection with disease pathogenesis and severity. The significant interstudy variation of the choice of diagnostic methods and criteria applied is most likely responsible for the great diversity of results observed. The use of well-standardized, commercially available diagnostic tools, as well as the adoption of a more unified diagnostic approach is probably the key element missing in order to clarify the exact role of C. pneumoniae in COPD.

Entities:  

Mesh:

Year:  2009        PMID: 19782917     DOI: 10.1016/j.ejim.2009.05.006

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  9 in total

1.  Ectopic lymphoid tissue formation in the lungs of mice infected with Chlamydia pneumoniae is associated with epithelial macrophage inflammatory protein-2/CXCL2 expression.

Authors:  P M Fitch; N M Wheelhouse; P Bowles; M Paterson; D Longbottom; G Entrican; S E M Howie
Journal:  Clin Exp Immunol       Date:  2010-09-14       Impact factor: 4.330

2.  Antibody response to chlamydiae in children with asthma and respiratory illness.

Authors:  J Kazár; E Kováčová; J Gašparovič; J Cervenka; K Furková; J Hornová; S Wimmerová
Journal:  Folia Microbiol (Praha)       Date:  2011-04-19       Impact factor: 2.099

3.  Severity of allergic airway disease due to house dust mite allergen is not increased after clinical recovery of lung infection with Chlamydia pneumoniae in mice.

Authors:  Pavel Dutow; Sandra Lingner; Robert Laudeley; Silke Glage; Heinz-Gerd Hoymann; Anna-Maria Dittrich; Beate Fehlhaber; Meike Müller; Armin Braun; Andreas Klos
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

4.  Caspase-1 dependent IL-1β secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection.

Authors:  Kenichi Shimada; Timothy R Crother; Justin Karlin; Shuang Chen; Norika Chiba; V Krishnan Ramanujan; Laurent Vergnes; David M Ojcius; Moshe Arditi
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

5.  Recombinant Cpn 0810 stimulates proinflammatory cytokine expression and apoptosis in human monocytes.

Authors:  Yuyu Chen; Baiping Wu; Liangzhuan Liu; Xiaoxing You; Lili Chen; Yimou Wu; Qiugui Zhang
Journal:  Exp Ther Med       Date:  2014-12-05       Impact factor: 2.447

6.  Relationship Among Chlamydia and Mycoplasma Pneumoniae Seropositivity, IKZF1 Genotype and Chronic Obstructive Pulmonary Disease in A General Japanese Population: The Nagahama Study.

Authors:  Shigeo Muro; Yasuharu Tabara; Hisako Matsumoto; Kazuya Setoh; Takahisa Kawaguchi; Meiko Takahashi; Isao Ito; Yutaka Ito; Kimihiko Murase; Chikashi Terao; Shinji Kosugi; Ryo Yamada; Akihiro Sekine; Takeo Nakayama; Kazuo Chin; Michiaki Mishima; Fumihiko Matsuda
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

7.  The relationship between glycated hemoglobin A1c levels and exacerbation status in the patients with chronic obstructive pulmonary disease.

Authors:  Behrang Motamed; Ali Alavi Foumani; Azita Tangestaninezhad; Mohammad Almasi; Niloofar Faraji; Alireza Jafarinezhad
Journal:  BMC Res Notes       Date:  2022-09-22

8.  A double-blind, randomised, placebo-controlled study of roxithromycin and doxycycline combination, roxithromycin alone, or matching placebo for 12 weeks in adults with frequent exacerbations of chronic obstructive pulmonary disease.

Authors:  Eskandarain Shafuddin; Graham D Mills; Mark D Holmes; Phillippa J Poole; Peter R Mullins; Peter N Black
Journal:  J Negat Results Biomed       Date:  2015-09-07

9.  In silico synteny based comparative genomics approach for identification and characterization of novel therapeutic targets in Chlamydophila pneumoniae.

Authors:  Bilachi S Ravindranath; Venkatappa Krishnamurthy; Venkatarangaiah Krishna; Sunil Kumar C
Journal:  Bioinformation       Date:  2013-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.